Juvenile myelomonocytic leukaemia, xanthoma, and neurofibromatosis type 1;Leucémie myélomonocytaire juvénile, xanthomes et neurofibromatose de type 1

Archives de Pediatrie

Volumn 10, Issue 10, 2003, Pages 891-894

  Benessahraoui, M ^a   Aubin, F ^a   Paratte, F ^a   Plouvier, E ^a   Humbert, P ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Infant; Myelomonocytic leukemia; Neurofibromatosis 1; Xanthomas

Indexed keywords

MERCAPTOPURINE;

ARTICLE; BLAST TRANSFORMATION; CAFE AU LAIT SPOT; CASE REPORT; CHILD; CHRONIC MYELOID LEUKEMIA; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GRANULOMA; HUMAN; MYELOMONOCYTIC LEUKEMIA; NEUROFIBROMATOSIS; TREATMENT OUTCOME; XANTHOMA;

EID: 0142088678     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)00456-1     Document Type: Article

References (17)

1. Denys T, Malbrain H. Contribution à l'étude des réticulo-endothélioses de l'enfant (la xantholeucémie). Arch Fr Pediatr 1954;11:707-16.
2. Royer P, Blondet C, Guihard J. Xantholeucémie du nourrisson et neurofibromatose de Recklinghausen. Ann Pediatr 1958;24:1504-13.
3. Altman AJ. Chronic leukemias of childhood. Pediatr Clin North Am 1988;35:765-87.
4. Jang KA, Choi JH, Sung KJ, Moon KC, Koh JK, Im DJ. Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma. J Dermatol 1999;26:33-5.
5. Dehen L, Zeller J, Cosnes A, Bernaudin F, Roujeau JC, Revuz J. Xanthogranulomes, neurofibromatose de type 1 et leucémie myélomonocytaire spontanément résolutive. Ann Dermatol Vénéréol 1990;117:812-4.
6. Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. Arch Dermatol 1995;131:904-8.
7. Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997;89:3534-43.
8. Cotter FE. Childhood myeloproliferative disorders. Baillieres Clin Haematol 1998;11:875-98.
9. Hasle H, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al. Myelodysplastic syndrome, juvenile myelomonocytic leukaemia, and acute myeloid leukaemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 1999;13:376-85.
10. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996;12:144-8.
11. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138-43.
12. Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 1994;70:969-72.
13. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-9.
14. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr 1978;92:925-9.
15. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Cuver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
16. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:597-601.
17. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukaemia without clinical evidence of neurofibromatosis type 1. Blood 1998;92:267-72.